Big Pharma giving more money to patient advocacy groups

Six drugmakers — J&J, AbbVie, Bristol-Myers Squibb, Pfizer, Merck and AstraZeneca — donated more than $680 million last year to hundreds of nonprofits, such as patient advocacy groups. Many of those nonprofits now campaign against federal legislation proposed to curb drug price increases.